Yimin Wu serves as Scientific Advisor in the Portfolio Management and Translational Projects Unit. She has more than 20 years of experience in malaria research and more than 10 years of experience in malaria vaccine development.
Prior to joining MVI, Yimin served as Product Manager/Specialist and then as head of the Product Development Unit at the Laboratory of Malaria Immunology and Vaccinology, formerly the Malaria Vaccine Development Branch, at the National Institute of Allergy and Infectious Diseases (NIAID) from 2003 to 2015. She managed the development of malaria vaccine candidates from manufacture release to preclinical and clinical evaluations, including regulatory submissions. She also led formulation research to improve the immunogenicity of malaria vaccine candidates, and led research and development of field-based assays to evaluate vaccine efficacy in malaria-endemic regions. Prior to NIAID, she headed the Malaria Program at the American Type Culture Collection, where she conducted malaria research and also served as founding director of the Malaria Research and Reference Reagent Resource Center, known as MR4.
Yimin received her BM from Shanghai University of Chinese Medicine, Shanghai, China and her PhD in biology from Southern Methodist University, Dallas, Texas. She began her career as a malaria researcher in postdoctoral training at NIAID and received the Hitchings-Elion Fellowship Award from the Burroughs-Wellcome Fund to continue research and training at Oxford University.